As of June 2024 Portage Biotech has a market cap of $9.47 Million. This makes Portage Biotech the world's 8194th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $9.47 M | -73.68% |
2023 | $35.99 M | -60.12% |
2022 | $90.26 M | -36.96% |
2021 | $0.14 B | -39.51% |
2020 | $0.23 B | 129.18% |
2019 | $0.10 B | 283.26% |
2018 | $26.94 M | -82.63% |
2017 | $0.15 B | 370.86% |
2016 | $32.94 M | 2.47% |
2015 | $32.15 M | 16.02% |
2014 | $27.71 M | -19.09% |
2013 | $34.25 M | 498.49% |
2012 | $5.72 M | 81.89% |
2011 | $3.14 M | -78.95% |
2010 | $14.94 M | -16.96% |
2009 | $17.99 M | 448.72% |
2008 | $3.28 M | -59.25% |
2007 | $8.04 M | 9.27% |
2006 | $7.36 M | 94.47% |
2005 | $3.78 M | -80.13% |
2004 | $19.05 M | 217.59% |
2003 | $6 M | 1284.57% |
2002 | $0.43 M | -20.31% |
2001 | $0.54 M |
On Jun 1st, 2024 the market cap of Portage Biotech was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $18.25 M | 92.65% | Bahamas |
NRC Health
NRC | $0.67 B | 6,976.44% | ๐บ๐ธ USA |